Myopathic carnitine deficiency
- The Centers for Mendelian Genomics program is working to discover the causes of rare genetic disorders. For more information about applying to the research study, please visit their website.
(Sigma-Tau Pharmaceuticals, Inc.)
The FDA has approved this product to be used in this manner.
|Treatment of primary and secondary carnitine deficiency.|
|More Information about this product||
Drug Information Portal
Medline Plus Health Information